Company intelligence / Profile preview

NeoGenex

Houston, Texas, USA

Ownership: Private
Employees: ~10
Development stage: Other

Overview

NeoGenex Biosciences is a biotechnology company specializing in the development of advanced liquid biopsy technologies for oncology. The company's primary focus is the isolation and characterization of circulating tumor cells (CTCs) from blood samples using its proprietary microfluidic and immunomagnetic platforms. These tools are designed to enable non-invasive cancer monitoring, early detection, and personalized treatment selection. NeoGenex provides both research-use-only (RUO) products and clinical diagnostic services to support oncology research and patient care.

Therapeutic areas: Oncology
Modalities: AntibodyDiagnosticLiquid Biopsy
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on NeoGenex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoGenex.

Explore the full profile